Back
Ellington Credit Co. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
30
EARN
Ellington Credit Co.
Last Price:
$4.56
Seasonality Move:
6.86%
Sell
17
NONOF
Novo Nordisk A/S
Last Price:
$35.59
Seasonality Move:
4.8%
Sell
30
Ellington Credit Co. (EARN)
is a Sell
Is Ellington Credit Co. a Buy, Sell or Hold?
-
The current Ellington Credit Co. [EARN] share price is $4.58. The Score for EARN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
EARN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EARN Stock Price Chart
What is Ellington Credit Co.'s stock price today?
-
The Ellington Credit Co. share price today is $4.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EARN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $35.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
EARN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 47.53 | Sell |
| Chaikin Money Flow: | 283395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.37 - 4.75) | Buy |
| Bollinger Bands (100): | (4.76 - 5.48) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 34 | Sell |
| Chaikin Money Flow: | -84014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 38.44) | Sell |
| Bollinger Bands (100): | (39.64 - 55.38) | Sell |
EARN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.47 | Buy |
| 20-day SMA: | 4.48 | Buy |
| 50-day SMA: | 4.93 | Sell |
| 200-day SMA: | 5.36 | Sell |
| 8-day EMA: | 4.4 | Buy |
| 20-day EMA: | 3.56 | Buy |
| 50-day EMA: | 2.1 | Buy |
| 200-day EMA: | 0.66 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Sell |
| 20-day SMA: | 37 | Sell |
| 50-day SMA: | 44.15 | Sell |
| 200-day SMA: | 53.01 | Sell |
| 8-day EMA: | 35.83 | Sell |
| 20-day EMA: | 37.34 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 54.32 | Sell |
Ellington Credit Co. Earnings Growth & EARN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.15 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ellington Credit Co. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||